| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-16 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-14 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-14 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-13 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-12 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-12 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-12 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-11 |